Recent News
On July 31, 2025, Azenta announced a collaboration with Frenova (a division of Fresenius Medical Care) and Nephronomics to advance genomic research in nephrology. On July 30, 2025, company management confirmed participation in the Needham Virtual MedTech & Diagnostics conference (August 12, 2025).
Technical Analysis
ADX / DI+ / DI-: ADX at 14.51 signals no established trend; both directional indicators point to weakening upside pressure as DI+ shows a peak-and-reversal while DI- shows a dip-and-reversal, a configuration that supports a near-term bearish bias against the current valuation.
MACD: MACD at -0.32 with a peak-and-reversal and a signal line at -0.16 indicates bearish momentum and aligns with technical pressure that could push price below short-term averages.
MRO (Momentum/Regression Oscillator): MRO at -29.16 indicates price below its regression target and therefore implies mean-reversion upside pressure; this creates a countervailing force that could produce a short bounce despite prevailing bearish momentum.
RSI: RSI at 47.62 with a peak-and-reversal signals waning buying interest and supports a modest downward bias while remaining inside a neutral band.
Price vs Moving Averages: Last close $28.17 sits below the 20-day ($30.01), 50-day ($30.64), and 200-day ($35.94) averages; the 12-day EMA shows a peak-and-reversal. This alignment reinforces short-to-intermediate technical pressure on price relative to the current valuation.
Bollinger Bands / Volatility / Volume: Price trades near the lower 1x Bollinger band ($28.85) while 42-day volatility reads 4% and 52-week volatility reads 3%. Daily volume (~591,827) runs under 10/50/200-day averages, indicating diminished conviction behind recent moves and increasing the chance of range-bound action or a low-volume bounce.
Fundamental Analysis
Profitability & Margins: Total revenue $143,942,000 and gross margin 47.08% contrast with an operating margin of 0.028% (EBIT $40,000). Operating and EBIT margins at 0.028% fall well below the industry peer mean (EBIT margin industry peer mean 14.576% and median 20.382%), indicating compressed operating profitability relative to peers.
Earnings: Reported EPS $0.19 versus an estimate of $0.14 produced an EPS surprise of 35.7%, reflecting a short-term upside to per-share profitability despite a net loss of $-52,806,000 for the period.
Cash, Liquidity, Leverage: Cash and short-term investments total $318,857,000 with a current ratio of 2.76 and a cash ratio of 1.30, supporting near-term obligations. Total debt $52,628,000 yields debt-to-assets of 2.61% and debt-to-EBITDA of 3.57x, a moderate leverage profile while preserving liquidity to fund operations or strategic initiatives.
Cash Flow & Efficiency: Free cash flow $14,971,000 and free cash flow yield 1.06% sit slightly above the industry peer mean free cash flow yield of 0.74%; operating cash flow $25,810,000 versus a negative cash flow margin of -7.98% signals timing differences and operating cash conversion that warrant monitoring.
Growth & Returns: Year-over-year revenue growth registers 0.37% while revenue contracted QoQ by -113.16%; earnings growth shows 280% on the provided metric but QoQ dynamics indicate uneven quarter-to-quarter performance. Return on equity -3.16% and return on assets -2.60% remain negative, reflecting recent losses despite scale in gross profit.
Efficiency Metrics: Asset turnover at 0.0709 sits below the industry peer mean of 0.1595, indicating lower revenue generation per dollar of assets. Cash conversion cycle ~137.9 days sits slightly below the industry peer mean of ~139.4 days, implying comparable working capital dynamics to peers.
Valuation: Market multiples show P/E ~167.8 and P/B ~0.85; price-to-sales ~9.86 and enterprise multiple ~78.12. The current valuation as determined by WMDST classifies the stock as over-valued, driven by elevated earnings multiples alongside thin operating margins and a material net loss.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-06-30 |
| REPORT DATE: | 2025-08-05 |
| NEXT REPORT DATE: | 2025-11-03 |
| CASH FLOW | Begin Period Cash Flow | $ 288.9 M |
| Operating Cash Flow | $ 25.8 M | |
| Capital Expenditures | $ -10.84 M | |
| Change In Working Capital | $ 10.8 M | |
| Dividends Paid | — | |
| Cash Flow Delta | $ 5.0 M | |
| End Period Cash Flow | $ 293.8 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 143.9 M | |
| Forward Revenue | $ -3.28 M | |
| COSTS | ||
| Cost Of Revenue | $ 76.2 M | |
| Depreciation | $ 14.7 M | |
| Depreciation and Amortization | $ 14.7 M | |
| Research and Development | $ 6.7 M | |
| Total Operating Expenses | $ 143.9 M | |
| PROFITABILITY | ||
| Gross Profit | $ 67.8 M | |
| EBITDA | $ 14.8 M | |
| EBIT | $ 40.0 K | |
| Operating Income | $ 40.0 K | |
| Interest Income | $ 5.0 M | |
| Interest Expense | — | |
| Net Interest Income | $ 5.0 M | |
| Income Before Tax | $ 3.4 M | |
| Tax Provision | $ 2.8 M | |
| Tax Rate | 21.0 % | |
| Net Income | $ -52.81 M | |
| Net Income From Continuing Operations | $ -52.81 M | |
| EARNINGS | ||
| EPS Estimate | $ 0.14 | |
| EPS Actual | $ 0.19 | |
| EPS Difference | $ 0.05 | |
| EPS Surprise | 35.714 % | |
| Forward EPS | $ 0.10 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 2.0 B | |
| Intangible Assets | $ 811.8 M | |
| Net Tangible Assets | $ 861.9 M | |
| Total Current Assets | $ 678.5 M | |
| Cash and Short-Term Investments | $ 318.9 M | |
| Cash | $ 270.0 M | |
| Net Receivables | $ 124.5 M | |
| Inventory | $ 80.5 M | |
| Long-Term Investments | $ 91.7 M | |
| LIABILITIES | ||
| Accounts Payable | $ 38.0 M | |
| Short-Term Debt | — | |
| Total Current Liabilities | $ 245.4 M | |
| Net Debt | — | |
| Total Debt | $ 52.6 M | |
| Total Liabilities | $ 345.5 M | |
| EQUITY | ||
| Total Equity | $ 1.7 B | |
| Retained Earnings | $ 1.4 B | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 36.55 | |
| Shares Outstanding | 45.785 M | |
| Revenue Per-Share | $ 3.14 | |
| VALUATION | Market Capitalization | $ 1.4 B |
| Enterprise Value | $ 1.2 B | |
| Enterprise Multiple | 78.118 | |
| Enterprise Multiple QoQ | -91.717 % | |
| Enterprise Multiple YoY | -64.865 % | |
| Enterprise Multiple IPRWA | high: 234.897 AZTA: 78.118 median: 76.655 mean: 69.049 low: -228.246 |
|
| EV/R | 8.011 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 1.206 | |
| Asset To Liability | 5.844 | |
| Debt To Capital | 0.03 | |
| Debt To Assets | 0.026 | |
| Debt To Assets QoQ | -0.913 % | |
| Debt To Assets YoY | 182.035 % | |
| Debt To Assets IPRWA | high: 1.297 mean: 0.242 median: 0.167 AZTA: 0.026 low: 0.002 |
|
| Debt To Equity | 0.031 | |
| Debt To Equity QoQ | -0.349 % | |
| Debt To Equity YoY | 191.474 % | |
| Debt To Equity IPRWA | high: 2.971 mean: 0.402 median: 0.266 AZTA: 0.031 low: -1.733 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 0.848 | |
| Price To Book QoQ | -8.555 % | |
| Price To Book YoY | -39.64 % | |
| Price To Book IPRWA | high: 19.098 median: 4.499 mean: 4.26 AZTA: 0.848 low: -7.981 |
|
| Price To Earnings (P/E) | 167.848 | |
| Price To Earnings QoQ | -75.655 % | |
| Price To Earnings YoY | -51.606 % | |
| Price To Earnings IPRWA | high: 246.592 AZTA: 167.848 median: 104.657 mean: 84.753 low: -204.468 |
|
| PE/G Ratio | 0.599 | |
| Price To Sales (P/S) | 9.861 | |
| Price To Sales QoQ | -10.379 % | |
| Price To Sales YoY | -39.067 % | |
| Price To Sales IPRWA | high: 154.906 mean: 20.843 median: 20.417 AZTA: 9.861 low: 0.297 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 292.402 | |
| Forward PE/G | 1.044 | |
| Forward P/S | -433.261 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | -274.569 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.071 | |
| Asset Turnover Ratio QoQ | 0.911 % | |
| Asset Turnover Ratio YoY | 0.24 % | |
| Asset Turnover Ratio IPRWA | high: 0.482 mean: 0.16 median: 0.135 AZTA: 0.071 low: 0.0 |
|
| Receivables Turnover | 1.051 | |
| Receivables Turnover Ratio QoQ | 11.538 % | |
| Receivables Turnover Ratio YoY | -2.036 % | |
| Receivables Turnover Ratio IPRWA | high: 3.864 mean: 1.493 median: 1.457 AZTA: 1.051 low: 0.477 |
|
| Inventory Turnover | 0.93 | |
| Inventory Turnover Ratio QoQ | -1.441 % | |
| Inventory Turnover Ratio YoY | 6.501 % | |
| Inventory Turnover Ratio IPRWA | high: 2.773 AZTA: 0.93 mean: 0.738 median: 0.714 low: 0.003 |
|
| Days Sales Outstanding (DSO) | 86.857 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 137.87 | |
| Cash Conversion Cycle Days QoQ | -8.664 % | |
| Cash Conversion Cycle Days YoY | -14.84 % | |
| Cash Conversion Cycle Days IPRWA | high: 401.407 mean: 139.415 AZTA: 137.87 median: 114.45 low: -252.738 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 0.332 | |
| CapEx To Revenue | -0.075 | |
| CapEx To Depreciation | -0.736 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 1.7 B | |
| Net Invested Capital | $ 1.7 B | |
| Invested Capital | $ 1.7 B | |
| Net Tangible Assets | $ 861.9 M | |
| Net Working Capital | $ 433.0 M | |
| LIQUIDITY | ||
| Cash Ratio | 1.299 | |
| Current Ratio | 2.764 | |
| Current Ratio QoQ | -14.137 % | |
| Current Ratio YoY | -42.129 % | |
| Current Ratio IPRWA | high: 16.236 AZTA: 2.764 mean: 2.262 median: 1.849 low: 0.353 |
|
| Quick Ratio | 2.436 | |
| Quick Ratio QoQ | -14.274 % | |
| Quick Ratio YoY | -42.098 % | |
| Quick Ratio IPRWA | high: 9.867 AZTA: 2.436 mean: 1.641 median: 1.303 low: 0.411 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 3.565 | |
| Cost Of Debt | 0.015 % | |
| Interest Coverage Ratio | 4.0 | |
| Interest Coverage Ratio QoQ | -100.318 % | |
| Interest Coverage Ratio YoY | -100.315 % | |
| Interest Coverage Ratio IPRWA | high: 274.877 mean: 25.49 median: 15.82 AZTA: 4.0 low: -384.45 |
|
| Operating Cash Flow Ratio | -0.047 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 45.394 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | -1.116 % | |
| Revenue Growth | 0.365 % | |
| Revenue Growth QoQ | -113.158 % | |
| Revenue Growth YoY | -95.752 % | |
| Revenue Growth IPRWA | high: 40.459 % median: 7.569 % mean: 7.504 % AZTA: 0.365 % low: -31.512 % |
|
| Earnings Growth | 280.0 % | |
| Earnings Growth QoQ | -846.667 % | |
| Earnings Growth YoY | 27.273 % | |
| Earnings Growth IPRWA | AZTA: 280.0 % high: 200.0 % median: 15.596 % mean: 14.638 % low: -227.273 % |
|
| MARGINS | ||
| Gross Margin | 47.075 % | |
| Gross Margin QoQ | 2.471 % | |
| Gross Margin YoY | 17.802 % | |
| Gross Margin IPRWA | high: 94.498 % mean: 57.001 % median: 56.435 % AZTA: 47.075 % low: 6.0 % |
|
| EBIT Margin | 0.028 % | |
| EBIT Margin QoQ | -100.319 % | |
| EBIT Margin YoY | -100.381 % | |
| EBIT Margin IPRWA | high: 33.87 % median: 20.382 % mean: 14.576 % AZTA: 0.028 % low: -1000.426 % |
|
| Return On Sales (ROS) | 0.028 % | |
| Return On Sales QoQ | -100.319 % | |
| Return On Sales YoY | -100.381 % | |
| Return On Sales IPRWA | high: 35.533 % median: 18.417 % mean: 12.934 % AZTA: 0.028 % low: -1349.836 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 15.0 M | |
| Free Cash Flow Yield | 1.055 % | |
| Free Cash Flow Yield QoQ | 138.149 % | |
| Free Cash Flow Yield YoY | -713.372 % | |
| Free Cash Flow Yield IPRWA | high: 11.539 % AZTA: 1.055 % mean: 0.736 % median: 0.679 % low: -40.868 % |
|
| Free Cash Growth | 114.024 % | |
| Free Cash Growth QoQ | -267.009 % | |
| Free Cash Growth YoY | -184.231 % | |
| Free Cash Growth IPRWA | high: 337.277 % AZTA: 114.024 % mean: 8.847 % median: -1.288 % low: -261.538 % |
|
| Free Cash To Net Income | -0.284 | |
| Cash Flow Margin | -7.979 % | |
| Cash Flow To Earnings | 0.217 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.04 | |
| Return On Assets (ROA) | -2.601 % | |
| Return On Assets QoQ | 31.231 % | |
| Return On Assets YoY | 866.914 % | |
| Return On Assets IPRWA | high: 19.773 % median: 2.151 % mean: 1.821 % AZTA: -2.601 % low: -72.965 % |
|
| Return On Capital Employed (ROCE) | 0.0 % | |
| Return On Equity (ROE) | -0.032 | |
| Return On Equity QoQ | 32.675 % | |
| Return On Equity YoY | 853.172 % | |
| Return On Equity IPRWA | high: 0.769 median: 0.035 mean: 0.002 AZTA: -0.032 low: -1.731 |
|
| DuPont ROE | -3.129 % | |
| Return On Invested Capital (ROIC) | 0.0 % | |
| Return On Invested Capital QoQ | -100.0 % | |
| Return On Invested Capital YoY | -100.0 % | |
| Return On Invested Capital IPRWA | high: 20.851 % median: 2.936 % mean: 2.932 % AZTA: 0.0 % low: -30.099 % |
|